Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
about
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters CommitteeThiopurine monitoring in children with inflammatory bowel disease: a systematic reviewThe Role of Laboratory Tests in Crohn's DiseasePharmacogenetics in inflammatory bowel diseaseLeucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideThioguanine in inflammatory bowel disease: Long-term efficacy and safetyRelationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disordersAllopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.Suspected azathioprine induced liver cirrhosis: an unusual side effect.Review article: acute severe ulcerative colitis - evidence-based consensus statements.Review article: monitoring for drug side-effects in inflammatory bowel disease.Therapeutic drug monitoring in patients with inflammatory bowel diseaseClinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.Pharmacogenomics and IBD: TPMT and thiopurines.Review article: practical management of inflammatory bowel disease patients taking immunomodulators.Review article: thiopurines in inflammatory bowel disease.Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Medical treatment of ulcerative colitisCurrent and future treatments of autoimmune hepatitis.Implementation of TPMT testing.Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?Thiopurine therapy in inflammatory bowel disease.Optimizing thiopurine therapy in inflammatory bowel disease.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.The role and advances of immunomodulator therapy for inflammatory bowel disease.Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Maintenance therapy options for ulcerative colitis.Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.TPMT in the treatment of Crohn's disease with azathioprine.Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease.Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration.Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel analysis.Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
P2860
Q22242348-AA3C789C-5F45-4A40-A8DE-2B23DA1E5518Q26859122-5F6DDDDA-5909-44ED-BA15-0C272F0504FEQ28075045-2AFEBFC7-F1C7-45D4-B1AE-10287F66355BQ28246002-F5C79323-E827-49ED-850A-253D3B730CDAQ28361611-AFDB3C6B-3C0E-407A-877E-1552E68B3271Q33731976-EF325B2A-F3B2-47D7-8E42-2E896BEED744Q33876453-9F247C65-E02B-4FD8-AF6F-CEE87CBCBE04Q34446588-E5F8F486-199A-460D-8B43-40615006BD02Q34476152-6F4949DE-F26F-49F0-8F8A-E56631B9ED49Q34528270-096CF49E-2441-4B44-AD86-49B9A4A7F780Q34585315-A93F1743-0118-4D8F-B39F-FD7DF54EC5B0Q35140715-60ADFE97-56DB-4A2B-8E2C-031C329595FBQ35596702-D63D51A7-72F4-4A82-8A64-BA9A7A22CD1FQ35787643-3F32D534-243C-42C1-AECF-BCBF7F5878A3Q36166363-BAE790E9-F458-48FC-82F8-394F6926462FQ36570796-74CEE64A-122F-45BE-880B-A9569EDD4072Q36631430-934BA4C4-6CF9-48A2-8356-4FE33E224646Q36822402-CE2B9849-68C0-42EC-9ECF-4967C7A3710DQ37149572-7757AA15-8390-42B1-BD8C-D99AAD1BA594Q37345896-8048DF67-2495-4791-B035-216BE2C47879Q37427481-878469B2-929E-4844-9537-1C4C0927B388Q37503380-33C7C24A-DC24-461B-B13C-F4287F9AC906Q37678056-976653E1-6D44-4F8A-AF72-887D8382A11DQ37688050-C5DA5EBC-094D-4120-80E6-EFCC794E3E95Q37798819-FF1D10A9-8777-40E9-9559-B136D0F6C951Q37800458-8EEB84C0-7484-4910-AF05-D5F88A4E4518Q38179509-59C39C40-8CF9-4B18-8D76-73CAB1FA89FFQ38237701-6E74E43D-59FB-40A9-B53E-743F767ED00EQ38417177-30F0CB33-BC31-40BB-A0FF-D20E6636044AQ38501680-FC6696F6-AA7C-4156-8E35-CE8574F88934Q38563075-1BDA8F0E-EB24-43EC-B602-03593EDE6DA9Q38848140-ECFDF0AF-330C-4223-9068-4E02B932C1F7Q40551481-1A9FBD91-8679-4252-A03A-04D1C348FE8EQ41762842-493D5BB7-2262-4175-B260-0094469C96DBQ42758200-A8AFF8A4-6C99-40E1-8B02-A2B134524A9CQ43006248-F22640D1-C7CD-4340-B658-D0DDF8E6AE5EQ43159235-8A540029-1EFC-40FC-954D-3AD87FDA8B9FQ43532191-1976BA6E-AB8E-4684-8201-5BB69A94FEF8Q43699289-14D46674-73FC-4FAE-B9DE-EDD4E26163DDQ44148231-26A01724-FFFD-4C50-A812-CFEBDE45CC20
P2860
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@ast
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@en
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@nl
type
label
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@ast
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@en
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@nl
prefLabel
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@ast
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@en
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@nl
P2093
P2860
P3181
P356
P1433
P1476
Measurement of thiopurine meth ...... ith inflammatory bowel disease
@en
P2093
P2860
P304
P3181
P356
10.1136/GUT.49.5.665
P407
P577
2001-11-01T00:00:00Z